XETRA · MRK.DE
Merck KGaA
€150.30+€4.25 (+2.91%)
Merck KGaA’s quoted price sits in the upper half of its reported 52-week range, 0.86% below the high.
Loading market information…
XETRA · DRW3.DE · EUR
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 04:35 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
Drägerwerk AG & Co. KGaA’s quoted price sits in the upper half of its reported 52-week range, 15.95% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Drägerwerk AG & Co. KGaA’s forward annual dividend is €2.27 per share, paid annual. The forward yield is 2.15% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Drägerwerk AG & Co. KGaA’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Headquartered in Lübeck, Germany, and established in 1889, Drägerwerk AG & Co. KGaA is an international enterprise specializing in medical and safety technology, with operations spanning Europe, the Americas, Africa, Asia, and Australia. For the healthcare sector, the company engineers, produces, and commercializes comprehensive solutions, apparatus, and related services tailored for acute care environments, such as emergency, perioperative, critical, and perinatal settings. Key offerings in this domain include anesthesia equipment, respiratory ventilators, thermoregulation devices, patient monitoring systems, supply units, lighting, gas management solutions, software applications, and various consumables and accessories. In the realm of safety, Drägerwerk delivers products, integrated systems, and support for personal protection, gas detection, and holistic hazard management. These provisions serve diverse clients across industrial and mining sectors, as well as public services like fire departments, law enforcement, and disaster preparedness agencies. The safety product range features both stationary and mobile gas detection systems, personal protective gear, and devices for alcohol and drug screening. Furthermore, Drägerwerk extends its expertise through various training programs and services, alongside dedicated fire training facilities for emergency responders.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:54 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q4 2024 | Jan 15, 2025 | €4.05 | €1.08B |
|---|
| Q3 2024 | Oct 16, 2024 | €0.78 | €774.57M-3.76% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
€150.30+€4.25 (+2.91%)
Merck KGaA’s quoted price sits in the upper half of its reported 52-week range, 0.86% below the high.
€42.89+€0.30 (+0.7%)
Siemens Healthineers AG’s quoted price sits in the upper half of its reported 52-week range, 13.7% below the high.
€47.96+€1.93 (+4.19%)
Bayer Aktiengesellschaft’s quoted price sits in the upper half of its reported 52-week range, 11.05% below the high.
MX$953.08MX$0.00 (0.0%)
Bayer AG’s quoted price sits in the upper half of its reported 52-week range, 5.56% below the high.
€47.00+€0.67 (+1.44%)
Fresenius SE & Co. KGaA’s quoted price sits in the upper half of its reported 52-week range, 11.25% below the high.
€31.90-€0.40 (-1.24%)
Gerresheimer AG’s quoted price sits in the upper half of its reported 52-week range, 6.73% below the high.
€13.22-€0.08 (-0.6%)
Eckert & Ziegler SE’s quoted price sits in the lower half of its reported 52-week range, 24.33% below the high.
€22.75-€0.15 (-0.66%)
Stratec SE’s quoted price sits in the upper half of its reported 52-week range, 14.31% below the high.
